RADNOR, Pa., Sept. 20, 2016 -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against Quorum Health Corporation (NYSE:QHC) (“Quorum” or the “Company) on behalf of investors who (i) received shares of Quorum common stock in connection with the Company’s spin-off from Community Health Systems, Inc. (“CHS”) and/or (ii) purchased or acquired shares of Quorum common stock between May 2, 2016 and August 10, 2016, inclusive (the “Class Period”).
Quorum shareholders who purchased or acquired their common stock during the Class Period may, no later than November 8, 2016, petition the Court to be appointed as a lead plaintiff representative of the class.
Shareholders who wish to discuss their legal rights or interests are encouraged to contact Kessler Topaz Meltzer & Check attorneys Seamus Kaskela, Esq. or Adrienne Bell, Esq. at (888) 299 – 7706 or (610) 667–7706, or online at: https://www.ktmc.com/new-cases/quorum-health-corporation#join.
Quorum owns and operates 38 hospitals and related outpatient service centers in 16 states. Effective April 29, 2016, CHS (NYSE:CYH) completed a spin-off of Quorum, with CHS shareholders receiving one share of Quorum common stock for every four shares of CHS stock they owned as of April 22, 2016.
The shareholder complaint alleges that Quorum and certain of its executive officers made a series of false and misleading statements and/or failed to disclose to investors during the Class Period that: (i) a number of Quorum’s hospitals were underperforming at the time of the spin-off from CHS; (ii) various other indicators of impairment existed at the time of Quorum’s spin-off from CHS; and (iii) Quorum disregarded and/or failed to advise investors of the foregoing issues. The complaint further alleges that, as a result of the foregoing, Quorum’s public statements were materially false and misleading at all relevant times.
On August 10, 2016, Quorum reported its financial and operational results for its first quarter as a publicly traded company. For the quarter ended June 30, 2016, the Company reported a net loss of $245 million, or $(8.63) per share, which it blamed on over $250 million of asset impairment and goodwill charges “relating to the carryover allocation of goodwill” at the time of the spin-off transaction from CHS. Subsequently, Quorum’s Chief Financial Officer stated that “there were indications of impairment” at the time of the spin-off and thereafter.
Following this news, shares of the Company’s stock declined $4.99, or nearly 50%, to close on August 11, 2016 at $5.03 per share.
Quorum shareholders may, no later than November 8, 2016, petition the Court to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class in the action. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. For additional information, or to learn how to participate in this action, please visit https://www.ktmc.com/new-cases/quorum-health-corporation#join.
Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check. For more information about Kessler Topaz Meltzer & Check, please visit www.ktmc.com.
CONTACT: Kessler Topaz Meltzer & Check, LLP D. Seamus Kaskela, Esq. Adrienne O. Bell, Esq. 280 King of Prussia Road Radnor, PA 19087 (888) 299-7706 (610) 667-7706 [email protected]


Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Apple Turns 50: From Garage Startup to AI Crossroads
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand 



